MX9800774A - Uso de n-(pirrol-1-il)piridinaminas no sustituidas y sustituidas como agentes anticonvulsivos. - Google Patents

Uso de n-(pirrol-1-il)piridinaminas no sustituidas y sustituidas como agentes anticonvulsivos.

Info

Publication number
MX9800774A
MX9800774A MX9800774A MX9800774A MX9800774A MX 9800774 A MX9800774 A MX 9800774A MX 9800774 A MX9800774 A MX 9800774A MX 9800774 A MX9800774 A MX 9800774A MX 9800774 A MX9800774 A MX 9800774A
Authority
MX
Mexico
Prior art keywords
pyridinamines
pyrrol
unsubstituted
substituted
anticonvulsant agents
Prior art date
Application number
MX9800774A
Other languages
English (en)
Inventor
Francis P Huger
Sathapana Kongsamut
Craig P Smith
Lei Tang
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of MX9800774A publication Critical patent/MX9800774A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invencion se refiere a un método para el tratamiento de un paciente que necesita mitigar convulsiones, el cual comprende administrar a dicho paciente, una cantidad para aliviar las convulsiones de un compuesto de la formula (I), en donde R, R1, R2, R3, R4, m y n son como se definen en la misma. (Ver Formula).
MX9800774A 1995-07-27 1996-07-08 Uso de n-(pirrol-1-il)piridinaminas no sustituidas y sustituidas como agentes anticonvulsivos. MX9800774A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50807195A 1995-07-27 1995-07-27
PCT/US1996/011408 WO1997004777A1 (en) 1995-07-27 1996-07-08 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents

Publications (1)

Publication Number Publication Date
MX9800774A true MX9800774A (es) 1998-04-30

Family

ID=24021262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800774A MX9800774A (es) 1995-07-27 1996-07-08 Uso de n-(pirrol-1-il)piridinaminas no sustituidas y sustituidas como agentes anticonvulsivos.

Country Status (20)

Country Link
EP (1) EP0840609B1 (es)
JP (1) JP4189029B2 (es)
KR (1) KR100445629B1 (es)
CN (1) CN1184969C (es)
AR (1) AR003471A1 (es)
AT (1) ATE218343T1 (es)
AU (1) AU696007B2 (es)
CA (1) CA2225156C (es)
DE (1) DE69621617T2 (es)
DK (1) DK0840609T3 (es)
ES (1) ES2174081T3 (es)
HK (1) HK1015687A1 (es)
IL (1) IL122845A0 (es)
MX (1) MX9800774A (es)
NO (1) NO315148B1 (es)
NZ (1) NZ312577A (es)
PT (1) PT840609E (es)
TW (1) TW464497B (es)
WO (1) WO1997004777A1 (es)
ZA (1) ZA966254B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
WO1997004777A1 (en) 1997-02-13
DK0840609T3 (da) 2002-09-30
CN1191486A (zh) 1998-08-26
DE69621617D1 (de) 2002-07-11
EP0840609A1 (en) 1998-05-13
AU696007B2 (en) 1998-08-27
EP0840609B1 (en) 2002-06-05
PT840609E (pt) 2002-10-31
JP4189029B2 (ja) 2008-12-03
IL122845A0 (en) 1998-08-16
ES2174081T3 (es) 2002-11-01
CA2225156A1 (en) 1997-02-13
NO980334L (no) 1998-03-26
ATE218343T1 (de) 2002-06-15
KR19990035973A (ko) 1999-05-25
HK1015687A1 (en) 1999-10-22
AR003471A1 (es) 1998-08-05
TW464497B (en) 2001-11-21
NO315148B1 (no) 2003-07-21
JPH11510159A (ja) 1999-09-07
AU6454796A (en) 1997-02-26
CA2225156C (en) 2003-06-10
CN1184969C (zh) 2005-01-19
DE69621617T2 (de) 2003-01-02
KR100445629B1 (ko) 2004-10-14
ZA966254B (en) 1997-02-11
NZ312577A (en) 1999-08-30
NO980334D0 (no) 1998-01-26

Similar Documents

Publication Publication Date Title
TR199801244T2 (xx) Herpese kar�� �zellikler ta��yan fenil tiyazol t�revleri.
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
GB9308957D0 (en) Novel produgs
MX9601360A (es) Mezcla estabilizante sinergistica.
MX9606744A (es) Acidos hidroxamicos sustituidos por sulfonamido arilico como inhibidores de metaloproteinasa de matriz.
AU1026599A (en) Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
MY117896A (en) Quinazoline derivatives
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
PL343495A1 (en) Heterocyclically substituted amides used as calpain inhibitors
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
NO950849L (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
AU9021298A (en) Agmatine as a treatment for neuropathic pain
GR3034924T3 (en) Novel peptide derivatives
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
MX9708696A (es) Cefalosporinas antibacterianas.
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
CA2256013A1 (en) Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
MX9801190A (es) Inhibidores de prolil endopeptidasa.
HK1014011A1 (en) Cyclopeptolides
AU5644296A (en) Novel heterocyclic chemistry
MX9800774A (es) Uso de n-(pirrol-1-il)piridinaminas no sustituidas y sustituidas como agentes anticonvulsivos.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: CHILDRENS HOSPITAL MEDICAL CENTER

MM Annulment or lapse due to non-payment of fees